US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Elutia

1.08

-0.0700-6.09%

Post-market: 1.080.00000.00%16:10 EDT

Volume:120.71K

Turnover:135.84K

Market Cap:46.12M

PE:-1.09

High:1.19

Open:1.15

Low:1.06

Close:1.15

52wk High:3.46

52wk Low:0.5000

Shares:42.70M

Float Shares:15.39M

Volume Ratio:0.58

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9867

EPS(LYR):-1.8558

ROE:--

ROA:-23.37%

PB:1.67

PE(LYR):-0.58

Loading ...

Overview Company News Filings

Elutia Receives Nasdaq Notice for Failing to Meet Minimum Bid Price

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Aziyo Biologics (ELUT) and Ironwood Pharma (IRWD)

Elutia’s Earnings Call: Strategic Moves Amid Challenges

Aziyo Biologics (ELUT) Gets a Buy from Cantor Fitzgerald

Elutia Q3 revenue falls short of estimates, gross margin improves

SWK Holdings Q3 adjusted EPS beats estimates

Elutia Inc. reports Q3 net sales of $3.3 million

Elutia Q3 EPS $(0.19) Misses $(0.15) Estimate, Sales $3.323M Miss $6.650M Estimate

BRIEF-Elutia Q3 Revenue USD 3.323 Million

Elutia Q3 Gross Profit USD 1.853 Million

THOMSON REUTERS

Elutia Inc. unveils strategy to revolutionize breast reconstruction with drug-enhanced biomaterials

Elutia Inc. Appoints Guido J. Neels to Board of Directors as W. Matthew Zuga and Maybelle Jordan Step Down

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

Elutia Inc. Files Initial Statement of Beneficial Ownership for Director Guido J. Neels

The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%

Simply Wall St.

BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors

Press Release: Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Elutia closes sale of BioEnvelope business to Boston Scientific for 88 million

SWK Holdings Corp. Announces Full Repayment of Elutia Loan Following $27.8 Million Payoff

Elutia Inc - Plans NXT-41X Market Launch in First Half 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELUT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","market":"US","secType":"STK","nameCN":"Elutia","latestPrice":1.08,"timestamp":1773432000000,"preClose":1.15,"halted":0,"volume":120709,"hourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.08,"latestTime":"16:10 EDT","volume":3,"amount":3.24,"timestamp":1773432605138,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06086956521739117,"floatShares":15385260,"shares":42701200,"eps":-0.986746,"marketStatus":"Market Closed","change":-0.07,"latestTime":"03-13 16:00:00 EDT","open":1.15,"high":1.19,"low":1.06,"amount":135837.8567,"amplitude":0.113043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.986746,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"listingDate":1602129600000,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.15,"preClose":1.15,"latestTime":"08:00 EDT","volume":4,"amount":4.6,"timestamp":1773403204799,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.08,"latestTime":"16:10 EDT","volume":3,"amount":3.24,"timestamp":1773432605138,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5772964833782963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","floatShares":15385260,"roa":"-23.37%","roe":"--","lyrEps":-1.855759,"volumeRatio":0.5772964833782963,"shares":42701200,"dividePrice":0,"high":1.19,"amplitude":0.113043,"preClose":1.15,"low":1.06,"week52Low":0.5,"pbRate":"1.67","psRate":"3.75","week52High":3.46,"institutionHeld":0,"latestPrice":1.08,"eps":-0.986746,"divideRate":0,"volume":120709,"delay":0,"ttmEps":-0.986746,"open":1.15,"prevYearClose":0.6927,"prevWeekClose":1.09,"prevMonthClose":1.15,"prevQuarterClose":0.6927,"fiveDayClose":1.09,"twentyDayClose":0.9513,"sixtyDayClose":0.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-11","symbol":"ELUT","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773201600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2026-01-12","symbol":"ELUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"ELUT","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-08-14","symbol":"ELUT","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-05-08","symbol":"ELUT","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELUT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1695960000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELUT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELUT","date":"2026-03-12","current":-1.094507,"percent":0.63289,"low":-4.772906,"twenty":-2.26327,"median":-1.906939,"eighty":-1.42516,"high":-0.540943,"avg":-1.904375,"sd":0.633511,"marketCap":46652000},"quantilePoints":[{"date":"2023-09-15","current":-0.550518,"twenty":-0.608921,"median":-0.57924,"eighty":-0.548603,"marketCap":18687324},{"date":"2023-09-22","current":-0.732428,"twenty":-0.740087,"median":-0.598389,"eighty":-0.548603,"marketCap":24862265},{"date":"2023-09-29","current":-0.925604,"twenty":-0.854822,"median":-0.732428,"eighty":-0.573496,"marketCap":31419614},{"date":"2023-10-06","current":-0.877962,"twenty":-0.929687,"median":-0.810097,"eighty":-0.59073,"marketCap":29802428},{"date":"2023-10-13","current":-0.925604,"twenty":-0.925604,"median":-0.860947,"eighty":-0.599346,"marketCap":31419614},{"date":"2023-10-20","current":-0.89838,"twenty":-0.951466,"median":-0.884768,"eighty":-0.62041,"marketCap":30495508},{"date":"2023-10-27","current":-0.78268,"twenty":-0.946021,"median":-0.884768,"eighty":-0.631899,"marketCap":26568056},{"date":"2023-11-03","current":-0.911992,"twenty":-0.929687,"median":-0.884768,"eighty":-0.712322,"marketCap":30957561},{"date":"2023-11-10","current":-1.000469,"twenty":-0.959633,"median":-0.891574,"eighty":-0.763066,"marketCap":33960907},{"date":"2023-11-17","current":-1.104073,"twenty":-0.980051,"median":-0.89838,"eighty":-0.780289,"marketCap":37297800},{"date":"2023-11-24","current":-1.270365,"twenty":-0.999262,"median":-0.911992,"eighty":-0.786996,"marketCap":42915471},{"date":"2023-12-01","current":-1.256631,"twenty":-1.107415,"median":-0.925604,"eighty":-0.801891,"marketCap":42451520},{"date":"2023-12-08","current":-1.373368,"twenty":-1.121435,"median":-0.939215,"eighty":-0.813987,"marketCap":46395104},{"date":"2023-12-15","current":-1.359634,"twenty":-1.252511,"median":-0.959633,"eighty":-0.824876,"marketCap":45931152},{"date":"2023-12-22","current":-1.339033,"twenty":-1.319806,"median":-0.973245,"eighty":-0.842572,"marketCap":45235226},{"date":"2023-12-29","current":-1.45577,"twenty":-1.339033,"median":-0.980051,"eighty":-0.854822,"marketCap":49178810},{"date":"2024-01-05","current":-1.929581,"twenty":-1.359634,"median":-0.986857,"eighty":-0.867073,"marketCap":65185121},{"date":"2024-01-12","current":-2.217989,"twenty":-1.373368,"median":-1.000469,"eighty":-0.876601,"marketCap":74928092},{"date":"2024-01-19","current":-2.423994,"twenty":-1.431049,"median":-1.101384,"eighty":-0.882046,"marketCap":81887358},{"date":"2024-01-26","current":-2.746735,"twenty":-1.572506,"median":-1.114716,"eighty":-0.884768,"marketCap":92790208},{"date":"2024-02-02","current":-2.526996,"twenty":-1.981769,"median":-1.12197,"eighty":-0.888852,"marketCap":85366991},{"date":"2024-02-09","current":-2.544163,"twenty":-2.252323,"median":-1.229164,"eighty":-0.891574,"marketCap":85946930},{"date":"2024-02-16","current":-2.629999,"twenty":-2.386913,"median":-1.263498,"eighty":-0.895658,"marketCap":88846624},{"date":"2024-02-23","current":-2.307258,"twenty":-2.444594,"median":-1.290965,"eighty":-0.89838,"marketCap":77943774},{"date":"2024-03-01","current":-2.499529,"twenty":-2.444594,"median":-1.339033,"eighty":-0.901102,"marketCap":84439089},{"date":"2024-03-08","current":-2.465195,"twenty":-2.469315,"median":-1.352767,"eighty":-0.907908,"marketCap":83279211},{"date":"2024-03-15","current":-2.101428,"twenty":-2.462448,"median":-1.366501,"eighty":-0.914714,"marketCap":79131372},{"date":"2024-03-22","current":-2.062751,"twenty":-2.444594,"median":-1.373368,"eighty":-0.92152,"marketCap":77674966},{"date":"2024-03-28","current":-2.030521,"twenty":-2.423994,"median":-1.407702,"eighty":-0.925604,"marketCap":76461295},{"date":"2024-04-05","current":-1.991844,"twenty":-2.422621,"median":-1.469503,"eighty":-0.926965,"marketCap":75004889},{"date":"2024-04-12","current":-1.959549,"twenty":-2.40614,"median":-1.575939,"eighty":-0.933771,"marketCap":73788790},{"date":"2024-04-19","current":-1.96606,"twenty":-2.361505,"median":-1.8178,"eighty":-0.940576,"marketCap":74033952},{"date":"2024-04-26","current":-1.868793,"twenty":-2.353952,"median":-1.846646,"eighty":-0.948743,"marketCap":70371251},{"date":"2024-05-03","current":-1.810595,"twenty":-2.330605,"median":-1.843584,"eighty":-0.959633,"marketCap":68179759},{"date":"2024-05-10","current":-1.810595,"twenty":-2.314124,"median":-1.846646,"eighty":-0.960994,"marketCap":68179759},{"date":"2024-05-17","current":-1.644574,"twenty":-2.312751,"median":-1.842927,"eighty":-0.9678,"marketCap":78406723},{"date":"2024-05-24","current":-1.659896,"twenty":-2.304511,"median":-1.810595,"eighty":-0.974606,"marketCap":79137220},{"date":"2024-05-31","current":-1.644574,"twenty":-2.293524,"median":-1.794429,"eighty":-0.980051,"marketCap":78406723},{"date":"2024-06-07","current":-1.736507,"twenty":-2.272923,"median":-1.736507,"eighty":-0.980051,"marketCap":82789707},{"date":"2024-06-14","current":-1.976554,"twenty":-2.261937,"median":-1.746722,"eighty":-0.985496,"marketCap":94234167},{"date":"2024-06-21","current":-2.009118,"twenty":-2.238589,"median":-1.746722,"eighty":-0.993817,"marketCap":95786700},{"date":"2024-06-28","current":-2.447891,"twenty":-2.25919,"median":-1.772259,"eighty":-0.998457,"marketCap":116705635},{"date":"2024-07-05","current":-2.528717,"twenty":-2.308631,"median":-1.797662,"eighty":-1.000067,"marketCap":120559123},{"date":"2024-07-12","current":-2.644184,"twenty":-2.359446,"median":-1.814198,"eighty":-1.000469,"marketCap":126064106},{"date":"2024-07-15","current":-2.540264,"twenty":-2.362192,"median":-1.8178,"eighty":-1.000469,"marketCap":121109621},{"date":"2024-08-02","current":-1.974478,"twenty":-2.361505,"median":-1.830364,"eighty":-1.020114,"marketCap":94135205},{"date":"2024-08-09","current":-1.29534,"twenty":-2.353952,"median":-1.810595,"eighty":-1.09977,"marketCap":84501485},{"date":"2024-08-16","current":-1.754315,"twenty":-2.330605,"median":-1.781728,"eighty":-1.105744,"marketCap":114442745},{"date":"2024-08-23","current":-2.093692,"twenty":-2.314124,"median":-1.810595,"eighty":-1.112886,"marketCap":136581967},{"date":"2024-08-30","current":-2.140682,"twenty":-2.312751,"median":-1.830364,"eighty":-1.115007,"marketCap":139647398},{"date":"2024-09-06","current":-2.109355,"twenty":-2.307258,"median":-1.845034,"eighty":-1.116169,"marketCap":137603777},{"date":"2024-09-13","current":-2.271212,"twenty":-2.293524,"median":-1.853208,"eighty":-1.119295,"marketCap":148162483},{"date":"2024-09-20","current":-1.99971,"twenty":-2.272923,"median":-1.868793,"eighty":-1.124646,"marketCap":130451106},{"date":"2024-09-27","current":-2.04148,"twenty":-2.271212,"median":-1.875815,"eighty":-1.198295,"marketCap":133175933},{"date":"2024-10-04","current":-1.989268,"twenty":-2.26599,"median":-1.888192,"eighty":-1.198295,"marketCap":129769899},{"date":"2024-10-11","current":-1.957941,"twenty":-2.25919,"median":-1.894658,"eighty":-1.201697,"marketCap":127726278},{"date":"2024-10-18","current":-1.871792,"twenty":-2.245106,"median":-1.91272,"eighty":-1.229164,"marketCap":122106322},{"date":"2024-10-25","current":-1.68644,"twenty":-2.224855,"median":-1.894658,"eighty":-1.249764,"marketCap":110014901},{"date":"2024-10-31","current":-1.655113,"twenty":-2.224348,"median":-1.888192,"eighty":-1.255258,"marketCap":107971280},{"date":"2024-11-08","current":-1.978826,"twenty":-2.219235,"median":-1.891425,"eighty":-1.263969,"marketCap":129088692},{"date":"2024-11-15","current":-1.99971,"twenty":-2.191779,"median":-1.91095,"eighty":-1.269453,"marketCap":130451106},{"date":"2024-11-22","current":-2.764944,"twenty":-2.238694,"median":-1.926614,"eighty":-1.270365,"marketCap":149865500},{"date":"2024-11-29","current":-2.639886,"twenty":-2.266998,"median":-1.927383,"eighty":-1.284312,"marketCap":143087085},{"date":"2024-12-06","current":-2.748287,"twenty":-2.299018,"median":-1.929581,"eighty":-1.294648,"marketCap":148962642},{"date":"2024-12-13","current":-2.525108,"twenty":-2.344339,"median":-1.940802,"eighty":-1.305076,"marketCap":136865908},{"date":"2024-12-20","current":-2.250917,"twenty":-2.413049,"median":-1.95272,"eighty":-1.323927,"marketCap":122004205},{"date":"2024-12-27","current":-2.646262,"twenty":-2.438332,"median":-1.956124,"eighty":-1.334913,"marketCap":143432706},{"date":"2025-01-03","current":-2.168022,"twenty":-2.456241,"median":-1.957941,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-10","current":-2.168022,"twenty":-2.447891,"median":-1.959614,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-17","current":-2.046868,"twenty":-2.423994,"median":-1.970269,"eighty":-1.3459,"marketCap":110944334},{"date":"2025-01-24","current":-2.091504,"twenty":-2.423994,"median":-1.97769,"eighty":-1.356887,"marketCap":113363681},{"date":"2025-01-31","current":-1.976726,"twenty":-2.4185,"median":-1.976554,"eighty":-1.359634,"marketCap":107142503},{"date":"2025-02-07","current":-1.937476,"twenty":-2.411689,"median":-1.970269,"eighty":-1.365128,"marketCap":105015096},{"date":"2025-02-14","current":-2.114955,"twenty":-2.389925,"median":-1.974478,"eighty":-1.371995,"marketCap":114634800},{"date":"2025-02-21","current":-2.366383,"twenty":-2.395026,"median":-1.976726,"eighty":-1.373368,"marketCap":128262713},{"date":"2025-02-28","current":-2.329409,"twenty":-2.395026,"median":-1.980336,"eighty":-1.373368,"marketCap":126258608},{"date":"2025-03-07","current":-1.885712,"twenty":-2.395026,"median":-1.984047,"eighty":-1.389848,"marketCap":102209349},{"date":"2025-03-14","current":-2.414629,"twenty":-2.395026,"median":-1.984047,"eighty":-1.409075,"marketCap":130266818},{"date":"2025-03-21","current":-2.446524,"twenty":-2.415305,"median":-1.989268,"eighty":-1.43929,"marketCap":131987517},{"date":"2025-03-28","current":-2.008566,"twenty":-2.412303,"median":-1.989268,"eighty":-1.46401,"marketCap":108360122},{"date":"2025-04-04","current":-2.197341,"twenty":-2.410499,"median":-1.989268,"eighty":-1.510704,"marketCap":118544344},{"date":"2025-04-11","current":-1.691424,"twenty":-2.404863,"median":-1.989268,"eighty":-1.550532,"marketCap":91250629},{"date":"2025-04-17","current":-1.58571,"twenty":-2.39466,"median":-1.984722,"eighty":-1.546412,"marketCap":85547464},{"date":"2025-04-25","current":-1.638567,"twenty":-2.383364,"median":-1.984047,"eighty":-1.56571,"marketCap":88399046},{"date":"2025-05-02","current":-1.668771,"twenty":-2.381173,"median":-1.980336,"eighty":-1.579955,"marketCap":90028522},{"date":"2025-05-09","current":-1.507402,"twenty":-2.381173,"median":-1.976726,"eighty":-1.525919,"marketCap":81322850},{"date":"2025-05-16","current":-1.782652,"twenty":-2.375257,"median":-1.975516,"eighty":-1.539065,"marketCap":71106411},{"date":"2025-05-23","current":-1.741671,"twenty":-2.364707,"median":-1.96606,"eighty":-1.547751,"marketCap":69471781},{"date":"2025-05-30","current":-1.690446,"twenty":-2.361505,"median":-1.959614,"eighty":-1.562241,"marketCap":67428494},{"date":"2025-06-06","current":-1.876016,"twenty":-2.353952,"median":-1.959582,"eighty":-1.578036,"marketCap":74830508},{"date":"2025-06-13","current":-1.94817,"twenty":-2.333662,"median":-1.959549,"eighty":-1.587189,"marketCap":77708604},{"date":"2025-06-20","current":-1.845092,"twenty":-2.329409,"median":-1.957941,"eighty":-1.593106,"marketCap":73597038},{"date":"2025-06-27","current":-1.906939,"twenty":-2.322014,"median":-1.954422,"eighty":-1.615914,"marketCap":76063978},{"date":"2025-07-03","current":-2.154326,"twenty":-2.315702,"median":-1.957941,"eighty":-1.622499,"marketCap":85931737},{"date":"2025-07-11","current":-2.525406,"twenty":-2.330472,"median":-1.959549,"eighty":-1.625643,"marketCap":100733376},{"date":"2025-07-18","current":-2.092479,"twenty":-2.330472,"median":-1.96466,"eighty":-1.636057,"marketCap":83464797},{"date":"2025-07-25","current":-1.958478,"twenty":-2.323493,"median":-1.967056,"eighty":-1.638567,"marketCap":78119761},{"date":"2025-08-01","current":-2.092479,"twenty":-2.315702,"median":-1.975516,"eighty":-1.639273,"marketCap":83464797},{"date":"2025-08-08","current":-2.04094,"twenty":-2.314124,"median":-1.978826,"eighty":-1.643549,"marketCap":81409014},{"date":"2025-08-15","current":-2.216172,"twenty":-2.311316,"median":-1.979093,"eighty":-1.644574,"marketCap":88398677},{"date":"2025-08-22","current":-4.375164,"twenty":-2.330472,"median":-1.984047,"eighty":-1.645809,"marketCap":93269750},{"date":"2025-08-29","current":-4.633697,"twenty":-2.36303,"median":-1.984047,"eighty":-1.653314,"marketCap":98781144},{"date":"2025-09-05","current":-3.997309,"twenty":-2.381173,"median":-1.987333,"eighty":-1.657983,"marketCap":85214635},{"date":"2025-09-12","current":-2.605211,"twenty":-2.410499,"median":-1.989268,"eighty":-1.659896,"marketCap":55537896},{"date":"2025-09-19","current":-2.147808,"twenty":-2.412303,"median":-1.989268,"eighty":-1.659896,"marketCap":45786968},{"date":"2025-09-26","current":-2.048372,"twenty":-2.410499,"median":-1.991844,"eighty":-1.663291,"marketCap":43667201},{"date":"2025-10-03","current":-1.78447,"twenty":-2.404863,"median":-1.989268,"eighty":-1.667485,"marketCap":38041339},{"date":"2025-10-10","current":-1.755037,"twenty":-2.391382,"median":-1.989268,"eighty":-1.669575,"marketCap":37413888},{"date":"2025-10-17","current":-1.790039,"twenty":-2.382633,"median":-1.987333,"eighty":-1.670436,"marketCap":38160046},{"date":"2025-10-24","current":-1.801772,"twenty":-2.381173,"median":-1.984047,"eighty":-1.673392,"marketCap":38410178},{"date":"2025-10-31","current":-1.809727,"twenty":-2.381173,"median":-1.982946,"eighty":-1.678283,"marketCap":38579760},{"date":"2025-11-07","current":-1.873763,"twenty":-2.372299,"median":-1.979093,"eighty":-1.68339,"marketCap":39944890},{"date":"2025-11-14","current":-1.189766,"twenty":-2.363868,"median":-1.977776,"eighty":-1.669575,"marketCap":31495498},{"date":"2025-11-21","current":-0.992038,"twenty":-2.360132,"median":-1.974478,"eighty":-1.659896,"marketCap":26261228},{"date":"2025-11-28","current":-0.987199,"twenty":-2.353927,"median":-1.967056,"eighty":-1.645192,"marketCap":26133125},{"date":"2025-12-05","current":-1.11689,"twenty":-2.343954,"median":-1.961437,"eighty":-1.638567,"marketCap":29566300},{"date":"2025-12-12","current":-1.125278,"twenty":-2.33781,"median":-1.958478,"eighty":-1.602229,"marketCap":29788346},{"date":"2025-12-19","current":-0.875413,"twenty":-2.332599,"median":-1.957941,"eighty":-1.547751,"marketCap":23173933},{"date":"2025-12-26","current":-0.902029,"twenty":-2.32793,"median":-1.954422,"eighty":-1.509472,"marketCap":23878502},{"date":"2026-01-02","current":-1.117373,"twenty":-2.322014,"median":-1.951783,"eighty":-1.449792,"marketCap":29579110},{"date":"2026-01-09","current":-1.113825,"twenty":-2.314124,"median":-1.94817,"eighty":-1.414569,"marketCap":29485168},{"date":"2026-01-16","current":-1.317047,"twenty":-2.314124,"median":-1.943688,"eighty":-1.373368,"marketCap":34864880},{"date":"2026-01-23","current":-1.632971,"twenty":-2.311316,"median":-1.939139,"eighty":-1.373368,"marketCap":43228000},{"date":"2026-01-30","current":-1.697643,"twenty":-2.307929,"median":-1.929581,"eighty":-1.373368,"marketCap":44940000},{"date":"2026-02-06","current":-1.523837,"twenty":-2.296271,"median":-1.927383,"eighty":-1.379079,"marketCap":40339000},{"date":"2026-02-13","current":-1.538064,"twenty":-2.277043,"median":-1.926614,"eighty":-1.396769,"marketCap":40715640},{"date":"2026-02-20","current":-1.810819,"twenty":-2.271896,"median":-1.919337,"eighty":-1.409075,"marketCap":47936000},{"date":"2026-02-27","current":-1.859323,"twenty":-2.269591,"median":-1.910677,"eighty":-1.415425,"marketCap":49220000},{"date":"2026-03-06","current":-1.794651,"twenty":-2.266998,"median":-1.910403,"eighty":-1.418151,"marketCap":47508000},{"date":"2026-03-12","current":-1.762315,"twenty":-2.26327,"median":-1.906939,"eighty":-1.42516,"marketCap":46652000}],"updateTime":1773460411903},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELUT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582373010","title":"Elutia Receives Nasdaq Notice for Failing to Meet Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373010","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373010?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:02","pubTimestamp":1762948953,"startTime":"0","endTime":"0","summary":"Elutia Inc. has announced that it received a notice from the Nasdaq Stock Market stating that its Class A common stock has closed below the $1.00 minimum bid price required for continued listing for the past 30 consecutive business days. The company now has 180 calendar days, until May 6, 2026, to regain compliance by having its stock close at or above $1.00 per share for at least ten consecutive business days. If Elutia does not regain compliance within this period, it may be eligible for an additional 180-day extension if it meets other listing requirements and notifies Nasdaq of its intent to resolve the deficiency, potentially through a reverse stock split. Failure to comply could result in the stock being delisted from Nasdaq.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLc215Yk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2582803647","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Aziyo Biologics (ELUT) and Ironwood Pharma (IRWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582803647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582803647?lang=en_us&edition=fundamental","pubTime":"2025-11-10 23:40","pubTimestamp":1762789238,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB – Research Report), Aziyo Biologics (ELUT – Research...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-aziyo-biologics-elut-and-ironwood-pharma-irwd-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-aziyo-biologics-elut-and-ironwood-pharma-irwd-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","GMAB","XBI","LU0029874061.USD","BK4588","XLV","BK4139","ELUT","IRWD","LABU","BK4585","HCSG","BK4137"],"gpt_icon":0},{"id":"2581858722","title":"Elutia’s Earnings Call: Strategic Moves Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2581858722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581858722?lang=en_us&edition=fundamental","pubTime":"2025-11-08 09:06","pubTimestamp":1762564014,"startTime":"0","endTime":"0","summary":"Aziyo Biologics, Inc. Class A (($ELUT)) has held its Q3 earnings call. Read on for the main highlights of the call. Elutia’s recent earnings call c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elutias-earnings-call-strategic-moves-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elutias-earnings-call-strategic-moves-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT"],"gpt_icon":0},{"id":"2581884162","title":"Aziyo Biologics (ELUT) Gets a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2581884162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581884162?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:06","pubTimestamp":1762528001,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Ross Osborn reiterated a Buy rating on Aziyo Biologics yesterday and set a price target of $2.00. Osborn covers the Healt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aziyo-biologics-elut-gets-a-buy-from-cantor-fitzgerald-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aziyo-biologics-elut-gets-a-buy-from-cantor-fitzgerald-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2581049217","title":"Elutia Q3 revenue falls short of estimates, gross margin improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2581049217","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581049217?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:32","pubTimestamp":1762468330,"startTime":"0","endTime":"0","summary":"Elutia Q3 revenue falls short of estimates, gross margin improvesOverviewElutia Q3 revenue missed analyst expectationsCompany completed $88 mln sale of BioEnvelope business to Boston ScientificGross m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0950375773.USD","BK4588","LU0251132253.USD","LU0122379950.USD","BK4082","LU0882574055.USD","LU0353189763.USD","LU1718418525.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4581","LU2491050154.USD","LU1983299246.USD","LU0823417737.USD","BK4585","IE0002141913.USD","LU2362540622.SGD","LU1791710582.SGD","LU0048584097.USD","LU2112291526.USD","LU0345769128.USD","LU0011850046.USD","BSX","LU1023059063.AUD","LU1366192091.USD","LU1153585028.USD","LU0266013472.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU1791710400.SGD","IE00B4R5TH58.HKD","SG9999013999.USD","LU0823417653.USD","ELUT","LU0353189680.USD","LU2265009873.SGD","LU0077335932.USD","LU0225283273.USD","LU0432979614.USD","LU1804176565.USD","LU0267386448.USD","LU2491050071.SGD","SG9999001176.SGD","LU0823416689.USD","IE0009355771.USD","LU1720051017.SGD","LU1291159041.SGD","SGXZ57979304.SGD","LU2324357040.USD","LU2242649171.HKD"],"gpt_icon":0},{"id":"2581049180","title":"SWK Holdings Q3 adjusted EPS beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581049180","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581049180?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:23","pubTimestamp":1762467825,"startTime":"0","endTime":"0","summary":"SWK Holdings Q3 adjusted EPS beats estimatesOverviewSWK Holdings Q3 revenue rose 4.8% year-over-year to $10.9 mlnAdjusted EPS for Q3 beats consensus, driven by finance receivables segmentSWK Holdings ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1UG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWKH","BK4164","BK4139","ELUT"],"gpt_icon":0},{"id":"2581004801","title":"Elutia Inc. reports Q3 net sales of $3.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581004801","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581004801?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:26","pubTimestamp":1762464408,"startTime":"0","endTime":"0","summary":"Elutia Inc. reported third quarter 2025 net sales of $3.3 million, down from $3.7 million in the same period of 2024. Net sales of SimpliDerm were $2.4 million, compared to $3.1 million in the prior year quarter, while net sales of Cardiovascular products rose to $0.9 million from $0.6 million. Gross margin was 55.8%, up from 48.9%. The company reported a net loss from discontinued operations of $3.5 million, compared to a net loss of $2.1 million in the previous year. Adjusted EBITDA was a loss of $2.7 million, similar to the prior year. As of September 30, 2025, cash balance was $4.7 million. On October 1, 2025, Elutia closed the $88 million sale of its BioEnvelope business to Boston Scientific Corporation, receiving $80.3 million, of which $27.8 million was used to pay off its loan facility and $8 million was placed in escrow. The proceeds will help fund the development of NXT-41x.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL2kwrK3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0187121727.USD","LU0266013472.USD","LU0353189680.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU0432979614.USD","LU0345769631.USD","LU0950375773.USD","LU2506951958.HKD","LU1989772923.USD","IE00B4R5TH58.HKD","ELUT","LU1291159041.SGD","LU1718418525.SGD","SG9999001176.USD","LU2324357040.USD","IE0009355771.USD","LU0225283273.USD","LU1720051017.SGD","LU1983299246.USD","LU2242649171.HKD","BSX","LU0251132253.USD","LU1153585028.USD","LU2362541273.HKD","LU0345769128.USD","LU0267386448.USD","BK4585","LU0823417737.USD","LU2112291526.USD","LU2506951875.HKD","LU0353189763.USD","BK4588","LU2244417387.USD","LU2362540622.SGD","LU0823416689.USD","LU1023059063.AUD","LU1989772840.SGD","LU1989771016.USD","BK4581","IE00B2B36J28.USD","LU0882574055.USD","LU2506952097.USD","LU0077335932.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","SG9999013999.USD","BK4082","BK4139"],"gpt_icon":0},{"id":"2581017143","title":"Elutia Q3 EPS $(0.19) Misses $(0.15) Estimate, Sales $3.323M Miss $6.650M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581017143","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581017143?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:06","pubTimestamp":1762463217,"startTime":"0","endTime":"0","summary":"Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.15) by 22.58 percent. This is a 42.42 percent increase over losses of $(0.33) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48703400/elutia-q3-eps-0-19-misses-0-15-estimate-sales-3-323m-miss-6-650m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Elutia Q3 EPS $(0.19) Misses $(0.15) Estimate, Sales $3.323M Miss $6.650M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2581501774","title":"BRIEF-Elutia Q3 Revenue USD 3.323 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581501774","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581501774?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:06","pubTimestamp":1762463160,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Q3 Revenue USD 3.323 Million\n\n\nNov 06 (Reuters) - Elutia Q3 gross profit USD 1.853 million.\n\nQ3 income from operations USD -5.208 million\nQ3 operating expenses USD 7.061 million\nQ3 net income USD -3.868 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXC679A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2581310017","title":"Elutia Q3 Gross Profit USD 1.853 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581310017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581310017?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463115,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXC679A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2577807645","title":"Elutia Inc. unveils strategy to revolutionize breast reconstruction with drug-enhanced biomaterials","url":"https://stock-news.laohu8.com/highlight/detail?id=2577807645","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577807645?lang=en_us&edition=fundamental","pubTime":"2025-10-22 04:52","pubTimestamp":1761079978,"startTime":"0","endTime":"0","summary":"Elutia Inc. recently delivered a presentation at the LD Micro Main Event XIX Conference, highlighting its strategy to replace traditional biologic materials with drug-enhanced biomaterials, initially focusing on breast reconstruction. The company emphasized its validated technology platform, including the development and sale of the first FDA-cleared drug-eluting bioenvelope for pacemakers to Boston Scientific for $88 million. Elutia is now leveraging this technology to address the $1.5 billion breast reconstruction market, where currently one in three patients experiences serious post-operative complications and one in seven faces infection. The company reports having the resources and infrastructure in place to support product clearance and commercialization. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL8yBNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952170.USD","LU1989764664.SGD","LU0238689110.USD","IE00B4R5TH58.HKD","LU0267386448.USD","LU2506952097.USD","LU2491050154.USD","BK4504","SG9999013999.USD","LU2324357040.USD","LU2506951958.HKD","LU2357305700.SGD","LU1989772840.SGD","LU1061106388.HKD","LU2491049909.HKD","LU0823417653.USD","IE0009355771.USD","SG9999001176.USD","LU0048584097.USD","LU1548497426.USD","LU2491050071.SGD","BSX","IE00BJJMRZ35.SGD","LU1057294990.SGD","SG9999001176.SGD","LU1983299246.USD","LU1791710400.SGD","LU2244417387.USD","LU2087625088.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU0528227936.USD","LU1989764748.USD","LU0114720955.EUR","LU0225283273.USD","LU0077335932.USD","ELUT","LU1291159041.SGD","LU1989772923.USD","LU1720051108.HKD","LU0011850046.USD","LU0251132253.USD","LU1366192091.USD","LU2265009873.SGD","LU1791710582.SGD","LU2362541273.HKD","LU0266013472.USD","LU2362541513.USD","IE0002141913.USD","BK4139"],"gpt_icon":0},{"id":"2575724087","title":"Elutia Inc. Appoints Guido J. Neels to Board of Directors as W. Matthew Zuga and Maybelle Jordan Step Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2575724087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575724087?lang=en_us&edition=fundamental","pubTime":"2025-10-15 05:01","pubTimestamp":1760475711,"startTime":"0","endTime":"0","summary":"Elutia Inc. has appointed Guido J. Neels to its Board of Directors. Neels will also join the company's audit committee. At the same time, W. Matthew Zuga and Maybelle Jordan have stepped down from the Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elutia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL6B4Lk8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2575244088","title":"Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21","url":"https://stock-news.laohu8.com/highlight/detail?id=2575244088","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575244088?lang=en_us&edition=fundamental","pubTime":"2025-10-15 04:05","pubTimestamp":1760472300,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Oct.  14, 2025  (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166645/0/en/Elutia-to-Present-at-the-LD-Micro-Main-Event-XIX-Conference-on-Tuesday-October-21.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LD","ELUT","BK4139"],"gpt_icon":0},{"id":"2575215700","title":"Elutia Inc. Files Initial Statement of Beneficial Ownership for Director Guido J. Neels","url":"https://stock-news.laohu8.com/highlight/detail?id=2575215700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575215700?lang=en_us&edition=fundamental","pubTime":"2025-10-14 21:26","pubTimestamp":1760448363,"startTime":"0","endTime":"0","summary":"Elutia Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Guido J. Neels as the beneficial owner, serving in the role of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elutia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL8M90Qr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2575559405","title":"The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575559405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575559405?lang=en_us&edition=fundamental","pubTime":"2025-10-13 18:23","pubTimestamp":1760350992,"startTime":"0","endTime":"0","summary":"To the annoyance of some shareholders, Elutia Inc. ( NASDAQ:ELUT ) shares are down a considerable 30% in the last...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-elut/elutia/news/the-market-doesnt-like-what-it-sees-from-elutia-incs-nasdaqe","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-elut/elutia/news/the-market-doesnt-like-what-it-sees-from-elutia-incs-nasdaqe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELUT",".IXIC"],"gpt_icon":0},{"id":"2574417592","title":"BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2574417592","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574417592?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:10","pubTimestamp":1760098234,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of DirectorsOct 10 (Reuters) - Elutia Inc ELUT.O:ELUTIA APPOINTS ACCOMPLISHED MEDTECH VETERAN GUIDO J. NEELS TO BOARD OF DIRE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nTUA16CFN5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2574175556","title":"Press Release: Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2574175556","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574175556?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:00","pubTimestamp":1760097600,"startTime":"0","endTime":"0","summary":"Industry leader brings 40 years of executive and board experience across the global medical technology sector. GAITHERSBURG, Md., Oct. 10, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix technologies, announced the appointment of Guido J. Neels to the Company's Board of Directors. Mr. Neels will also serve as a member of the audit committee of the Board. In conjunction with Mr. Neels' appointment, W. Matthew Zuga and Maybelle Jordan have both stepped down as members of Elutia's Board.\"Randy and I are excited to welcome Guido to our Board of Directors and the Elutia CRU,\" said Kevin Rakin, Executive Chairman of Elutia. \"Guido's extensive medical technology leadership experience encompasses a broad range of managerial and strategic roles. His insights will be invaluable as we embark on building significant shareholder value, leveraging our demonstrated drug-eluting biomatrix technology, following our recent EluPro divestiture. We also thank Matt Zuga and Maybelle Jordan for t","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","BK4504","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","IE00BN0W2V16.EUR","BK4082","BK4588","IE00BN0W2W23.USD","BK4585","BK4567","BK4139","R","IE00BN0W2T93.GBP","ELUT","EW"],"gpt_icon":0},{"id":"2573299658","title":"Elutia closes sale of BioEnvelope business to Boston Scientific for 88 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2573299658","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573299658?lang=en_us&edition=fundamental","pubTime":"2025-10-08 05:01","pubTimestamp":1759870883,"startTime":"0","endTime":"0","summary":"Elutia Inc. has completed the sale of its BioEnvelope business, including the EluPro and CanGaroo bioenvelopes, to Boston Scientific Corporation for $88 million in cash. With the transaction finalized, Elutia will focus on advancing its NXT-41x drug-eluting biomatrix platform, aimed at reducing reconstruction infections following mastectomy. The company plans to bring NXT-41x to market in the first half of 2027, targeting the $1.5 billion U.S. breast reconstruction biologics market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elutia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL7hgb1v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1989764664.SGD","LU1023059063.AUD","LU0882574055.USD","LU2324357040.USD","LU0950375773.USD","IE0002141913.USD","LU2362540622.SGD","LU2506951875.HKD","LU0823417737.USD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0225283273.USD","LU0011850046.USD","BK4082","LU1153585028.USD","SGXZ57979304.SGD","SG9999001176.USD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU1057294990.SGD","LU1548497426.USD","LU1720051017.SGD","LU2087625088.SGD","LU2491050154.USD","IE00B2B36J28.USD","LU0353189680.USD","LU0238689110.USD","LU2265009873.SGD","LU2506952097.USD","LU1791710582.SGD","LU2242649171.HKD","BK4581","BK4588","LU0345769631.USD","LU1791710400.SGD","BK4504","SG9999013999.USD","ELUT","LU0267386448.USD","LU1989772840.SGD","LU0251132253.USD","LU1718418525.SGD","BK4585","LU2244417387.USD","LU2362541273.HKD","BSX","IE00BJT1NW94.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2572550840","title":"SWK Holdings Corp. Announces Full Repayment of Elutia Loan Following $27.8 Million Payoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550840","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550840?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:39","pubTimestamp":1759351155,"startTime":"0","endTime":"0","summary":"SWK Holdings Corp. , a specialty finance company focused on the life sciences sector, announced on October 1, 2025, that Elutia, Inc. has fully repaid its loan with a $27.8 million payoff. This payment, which includes outstanding principal, exit fees, and accrued interest, follows Elutia's $88 million sale of its BioEnvelope business to Boston Scientific Corporation. The repayment exceeds SWK Holdings' net GAAP carrying value of the loan, and the company expects to recognize approximately $2.8 million in incremental income as a result of the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SWK Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL1DsKtX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0011850046.USD","LU0345769631.USD","IE00BJT1NW94.SGD","LU0950375773.USD","LU1989772840.SGD","LU2362541273.HKD","LU1989764664.SGD","LU1153585028.USD","LU0266013472.USD","LU1057294990.SGD","LU2357305700.SGD","LU2491049909.HKD","LU1366192091.USD","BK4581","LU2506952170.USD","LU0187121727.USD","LU2265009873.SGD","LU2087625088.SGD","LU1989772923.USD","LU1061106388.HKD","BSX","LU0823417653.USD","LU1023059063.AUD","LU1548497426.USD","LU0823416689.USD","LU2491050071.SGD","LU2491050154.USD","LU0114720955.EUR","BK4504","LU0048584097.USD","LU1989764748.USD","SG9999001176.USD","IE0002141913.USD","SGXZ57979304.SGD","LU1720051108.HKD","LU0345769128.USD","LU2112291526.USD","LU0353189680.USD","LU1718418525.SGD","SWKH","LU2362541513.USD","LU1983299246.USD","ELUT","LU0077335932.USD","LU0238689110.USD","LU2506952097.USD","LU0882574055.USD","BK4588","BK4082","LU1291159041.SGD"],"gpt_icon":0},{"id":"2572315965","title":"Elutia Inc - Plans NXT-41X Market Launch in First Half 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2572315965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572315965?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:41","pubTimestamp":1759322494,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUABGXC4L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LU2362540622.SGD","LU1291159041.SGD","LU0114720955.EUR","LU2506951875.HKD","LU2362541273.HKD","LU2491049909.HKD","LU2112291526.USD","LU2265009873.SGD","BK4504","LU2491050071.SGD","LU1366192091.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0048584097.USD","LU0077335932.USD","LU2324357040.USD","LU1153585028.USD","ELUT","LU0823417653.USD","LU1804176565.USD","IE00BJT1NW94.SGD","LU2506952097.USD","SG9999001176.SGD","LU0345769128.USD","LU2242649171.HKD","LU1720051108.HKD","LU0122379950.USD","LU1983299246.USD","IE0002141913.USD","LU0225283273.USD","LU1989771016.USD","LU1989772840.SGD","BSX","LU2362541513.USD","BK4585","LU0528227936.USD","LU0882574055.USD","LU0353189680.USD","LU1720051017.SGD","SG9999001176.USD","LU0251132253.USD","BK4581","LU2491050154.USD","LU2087625088.SGD","LU0345769631.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU0266013472.USD","LU2244417387.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":62,"code":"91000000","status":"200"}]}}